BioSpace News Archive

New and existing investors include SDL Ventures and Global Source Ventures.

AIVITA Biomedical Inc., a biotech company specializing in innovative stem cell applications, today announced that it will be presenting or exhibiting at the following conferences in June.

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the data on the intravenous (IV) formulation of NEPA (Akynzeo®) will be presented as poster at the American Society of Clinical Oncology (ASCO) Congress in June 2019 on the poster session Symptoms and Survivorship.

Veloxis Pharmaceuticals announced that the Company’s product, Envarsus XR, will be the subject of two oral and fifteen poster presentations at the American Transplant Congress June 1st-5th, 2019 in Boston, Massachusetts, USA.